Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker

IntroductionRALA is a member of the small GTPase Ras superfamily and has been shown to play a role in promoting cell proliferation and migration in most tumors, and increase the resistance of anticancer drugs such as imatinib and cisplatin. Although many literatures have studied the cancer-promoting...

Full description

Bibliographic Details
Main Authors: Haoer Jin, Sha Qin, Jiang He, Juxiong Xiao, Qingling Li, Yitao Mao, Luqing Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1046044/full

Similar Items